Press release
Potential Analysis of Ebola drug and Vaccines Market : Industry Size, Share, Segmentation And Groth to 2020
Intense Research
Ebola virus disease (EVD), also known as Ebola hemorrhagic fever (EHF), results from Ebola virus and three other closely related viruses in the genes (group of related viruses) of ebola virus. Initial symptoms of this disease include sore throat, headaches, fever and muscles pain. It causes hemorrhagic fever that leads to internal or external bleeding. EVD is widely prevalent in Central and Western Africa, and near tropical rainforests. Due to high mortality rate and unavailability of effective treatments, the pharmaceutical companies have big opportunities to explore. Tekmira Pharmaceuticals, BioCryst Pharmaceutical Inc., Serepata Therapeutics, NewLink Genetics and Mapp Biopharmaceutical are some of the leading companies focusing on research activities to develop efficacious medicine for EVD. Additionally, the governments in the developed countries have also taken formidable steps to support the research activities for the development of EVD therapeutics by providing funding and floating favorable policies. As an example, Tekmira Pharmaceuticals has received fast-track designation from U.S. food and drug administration for their anti-ebola therapeutic TKM-ebola. In 2012, Sarepta Therapeutics had also received fast track designation for AVI-7537, a lead drug candidate for EVD. Both these companies are developing their anti-ebola products under the contract of the U.S. department of defense (DoD).
Read Sample Report@http://goo.gl/95HqkA
Ebola therapeutics and vaccines market is segmented on the basis of geography into North America, Europe, Asia-pacific and LAMEA. EVD is rampant in LAMEA regions, specifically in African countries. This is a positive sign for pharmaceutical companies, portraying a highly lucrative market in the future. Earlier, US government did not have any regulations for EVD therapeutics due to negligible incidences of this disease in developed economies. However, preference of African people to migrate to developed economies rather than developing economies has cautioned the governments in the developed economies, leading to formulate regulations in order to curb the spread of this disease.
KEY BENEFITS
This report offers the following benefits in particular:
To track commercial trends, major clinical trials and their status are pursued of closely
The report sheds light on the key events held in past years concerning the development of ebola viral disease therapeutics
Pin-point analysis of geographic segments helps to identify opportunities for growth within the ebola therapeutics and vaccines market
Porter’s Five Forces analysis examines the competitive structure of the ebola therapeutics and vaccines market and would assist market strategists in their respective decision making process
In-depth coverage of the ebola therapeutics and vaccines market including drivers, restraints and opportunities would help professionals to better understand market behavior
Detailed study of the strategies of key leaders, partnerships and acquisitions in the ebola therapeutics and vaccines market would be informative for professionals in corporate sector
KEY MARKET SEGMENTS
Ebola therapeutics and vaccines market is segmented on the basis of geography.
LAMEA
North America
Europe
Asia-Pacific
About Us
Intense Research is a single destination for all the industry, company and country reports. We feature large repository of latest industry reports, leading and niche company profiles, and market statistics released by reputed private publishers and public organizations.
Contact Us
Joel John
3422 SW 15 Street, Suit #8138,
Deerfield Beach, Florida 33442,
United States
Tel: +1-386-310-3803
GMT Tel: +49-322 210 92714
USA/Canada Toll Free No. 1-855-465-4651
Email: admin@intenseresearch.com
Web: http://www.intenseresearch.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Potential Analysis of Ebola drug and Vaccines Market : Industry Size, Share, Segmentation And Groth to 2020 here
News-ID: 326989 • Views: …
More Releases from Intense Research
Global White Box Servers Market Manufacturing Base And Competitors Quanta, Wistr …
A white box server refers to customized servers that are either home built, or built by white box suppliers called ODMs (Original Design Manufacturers) such as Supermicro. The term white box simply means that the equipment is unbranded or generic. All parts are purchased separately which helps cut costs as well as provides hobbyists and data center professionals alike more customization to better fit their needs. The ease of customization…
Managed Mobility Services Market Future Trends 2020 - At&T, Fujitsu, IBM, Wipro, …
The research report "Managed Mobility Services Market: Global and Regional Analysis 2019 - 2024" discover accurate information about the long run prospects of this Managed Mobility Services market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Managed Mobility Services market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from the current Managed…
Global Signature Verification Market Professional Survey 2020 - Biometric Signat …
The research report "Signature Verification Market: Global and Regional Analysis 2019 - 2024" discover accurate information about the long run prospects of this Signature Verification market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Signature Verification market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from the current Signature Verification market, chapter…
Global Scientific and Technical Publication Market 2020 : Informa, John Wiley & …
The research report "Scientific and Technical Publication Market: Global and Regional Analysis 2019 - 2024" discover accurate information about the long run prospects of this Scientific and Technical Publication market, which can help industry players to understand the flow of the market throughout the period 2019-2024. The global Scientific and Technical Publication market has defined the market scenario in an orderly way, emphasizing the industrial development, prominent players engaged from…
More Releases for EVD
Impact Of Rising Ebola Virus Disease (EVD) Cases On the Ebanga Market: An Emergi …
The Ebanga Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Ebanga Market?
In recent times, the ebanga market size has experienced an XX (HCAGR). The projection suggests an increase from $XX million in 2024 to $XX million in 2025,…
What's Driving the Ebanga Market 2025-2034: Impact Of Rising Ebola Virus Disease …
What Is the Forecasted Market Size and Growth Rate for the Ebanga Market?
The size of the ebanga market has shown a progressive trend, having a HCAGR of $XX over recent years. It is projected to expand from $XX million in 2024 to an impressive $XX million come 2025, owing to a Compound Annual Growth Rate (CAGR) of $XX%. This growth during the historic period can be ascribed to multiple factors…
Intracranial Pressure Monitoring Devices Market By Device type (Subarachnoid bol …
Report Overview
The market for intracranial pressure monitoring devices was valued at USD 1.46 billion in 2021, and from 2023 to 2032, it is anticipated to increase at a compound annual growth rate (CAGR) of 6.9%. The market is expected to increase due to the rise in neurological illnesses, the ageing population in Asia Pacific, particularly in nations like China, Japan, and India, and rapid technological advancements. On the market, the…
Ebola Vaccine Market Detailed Analysis and Forecast 2018-2026 | Merck, Janssen P …
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…
Ebola Vaccine Market Analysis By Key Players Merck and Company, Janssen Pharmace …
In January 2018, GeoVax Labs Inc., published results tested in non-hamate primates for its experimental vaccine, GEO-EM01 against EVD. It is based on company’s novel Modified Vaccinia Ankara Virus like Particle (VLP) platform, which produces non-infectious VLPs in body of vaccinated individual. These VLP’S mimics the natural infection, which triggers the body to produce immune response with both antibodies and T cells.
Download PDF Brochure @ www.coherentmarketinsights.com/insight/request-pdf/1365
According to study published in…
Ebola Vaccine Market in Depth Analysis2026 | Top Key Players Merck and Company, …
In January 2018, GeoVax Labs Inc., published results tested in non-hamate primates for its experimental vaccine, GEO-EM01 against EVD. It is based on company’s novel Modified Vaccinia Ankara Virus like Particle (VLP) platform, which produces non-infectious VLPs in body of vaccinated individual. These VLP’S mimics the natural infection, which triggers the body to produce immune response with both antibodies and T cells.
According to study published in the journal, The Lancet,…
